` TOI (Oncology Institute Inc) vs S&P 500 Comparison - Alpha Spread

TOI
vs
S&P 500

Over the past 12 months, TOI has significantly outperformed S&P 500, delivering a return of +910% compared to the S&P 500's +15% growth.

Stocks Performance
TOI vs S&P 500

Loading
TOI
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
TOI vs S&P 500

Loading
TOI
S&P 500
Difference
www.alphaspread.com

Performance By Year
TOI vs S&P 500

Loading
TOI
S&P 500
Add Stock

Competitors Performance
Oncology Institute Inc vs Peers

S&P 500
TOI
HCA
4013
300015
RDOR3
Add Stock

Oncology Institute Inc
Glance View

Market Cap
359.3m USD
Industry
Health Care

The Oncology Institute, Inc. provides cancer care treatment services. The company is headquartered in Cerritos, California. The company went IPO on 2020-03-13. The firm manages community-based oncology practices that serve patients at approximately 55 clinic locations across eight markets and four states throughout the United States. The Company’s managed clinics provide a range of medical oncology services, including physician services, in-house infusion and dispensary, clinical trial services, programs like outpatient stem cell transplants and transfusions, along with 24/7 patient support. Through the Innovative Clinical Research Institute (ICRI), the Company also provides and manages clinical trial services and research for the benefit of cancer patients. Its services, such as managing clinical trials, palliative care programs and stem cell transplants, are accessed through academic and tertiary care settings. Its managed clinics primarily serve adult and senior cancer patients in markets that have Medicare Advantage (MA) plans.

TOI Intrinsic Value
3.11 USD
Overvaluation 23%
Intrinsic Value
Price
Back to Top